| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8845 |
| Human Intestinal Absorption | HIA+ | 0.9964 |
| Caco-2 Permeability | Caco2+ | 0.5379 |
| P-glycoprotein Substrate | Substrate | 0.7274 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8241 |
| Inhibitor | 0.9514 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6531 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7980 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8387 |
| CYP450 2D6 Substrate | Non-substrate | 0.8382 |
| CYP450 3A4 Substrate | Substrate | 0.6824 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9107 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.8949 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8931 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.8994 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.8123 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8031 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7136 |
| Non-inhibitor | 0.7040 |
| AMES Toxicity | Non AMES toxic | 0.5000 |
| Carcinogens | Non-carcinogens | 0.9402 |
| Fish Toxicity | High FHMT | 0.9989 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9997 |
| Honey Bee Toxicity | High HBT | 0.8734 |
| Biodegradation | Not ready biodegradable | 0.8044 |
| Acute Oral Toxicity | III | 0.4952 |
| Carcinogenicity (Three-class) | Non-required | 0.6340 |